Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Graff-Guerrero

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
Brain : a Journal of Neurology|April 5, 2017
Is antipsychotic sensitivity in Alzheimer's disease secondary to abnormal blood-brain barrier integrity?Fernando Caravaggio, Ariel Graff-Guerrero
Synapse (New York, N.Y.)|September 26, 2019
Further in vivo characterization of [<sup>11</sup> C]-(+)-PHNO uptake into a retina-like region of interest in humansFernando Caravaggio, Patrick Worhunsky, Ariel Graff-Guerrero, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 28, 2015
Examining endogenous dopamine in treated schizophrenia using [¹¹C]-(+)-PHNO positron emission tomography: A pilot studyFernando Caravaggio, Carol Borlido, Alan Wilson, et al.
Medical Hypotheses|April 25, 2018
Psychiatric benefits of lithium in water supplies may be due to protection from the neurotoxicity of lead exposureEric E Brown, Philip Gerretsen, Bruce Pollock, et al.
International Journal of Geriatric Psychiatry|July 25, 2014
The effects of aging on insight into illness in schizophrenia: a reviewPhilip Gerretsen, Eric Plitman, Tarek K Rajji, et al.
Journal of Gambling Studies|December 22, 2019
Impaired Awareness of Problem and Pathological Gambling: A ReviewParita Shah, Lena Quilty, Julia Kim, et al.
Psychiatry Research|February 11, 2017
Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction studyPhilip Gerretsen, Hiroyoshi Takeuchi, Miracle Ozzoude, et al.
Medical Hypotheses|June 30, 2015
Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophreniaFernando Caravaggio, Margaret Hahn, Shinichiro Nakajima, et al.
Current Alzheimer Research|March 12, 2019
Lead (Pb) in Alzheimer's Dementia: A Systematic Review of Human Case- Control StudiesEric E Brown, Parita Shah, Bruce G Pollock, et al.
Neuropsychologia|October 29, 2017
The neural correlates of apathy in schizophrenia: An exploratory investigationFernando Caravaggio, Gagan Fervaha, Mahesh Menon, et al.
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
Brain : a Journal of Neurology|April 5, 2017
Is antipsychotic sensitivity in Alzheimer's disease secondary to abnormal blood-brain barrier integrity?Fernando Caravaggio, Ariel Graff-Guerrero
Synapse (New York, N.Y.)|September 26, 2019
Further in vivo characterization of [<sup>11</sup> C]-(+)-PHNO uptake into a retina-like region of interest in humansFernando Caravaggio, Patrick Worhunsky, Ariel Graff-Guerrero, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 28, 2015
Examining endogenous dopamine in treated schizophrenia using [¹¹C]-(+)-PHNO positron emission tomography: A pilot studyFernando Caravaggio, Carol Borlido, Alan Wilson, et al.
Medical Hypotheses|April 25, 2018
Psychiatric benefits of lithium in water supplies may be due to protection from the neurotoxicity of lead exposureEric E Brown, Philip Gerretsen, Bruce Pollock, et al.
International Journal of Geriatric Psychiatry|July 25, 2014
The effects of aging on insight into illness in schizophrenia: a reviewPhilip Gerretsen, Eric Plitman, Tarek K Rajji, et al.
Journal of Gambling Studies|December 22, 2019
Impaired Awareness of Problem and Pathological Gambling: A ReviewParita Shah, Lena Quilty, Julia Kim, et al.
Psychiatry Research|February 11, 2017
Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction studyPhilip Gerretsen, Hiroyoshi Takeuchi, Miracle Ozzoude, et al.
Medical Hypotheses|June 30, 2015
Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophreniaFernando Caravaggio, Margaret Hahn, Shinichiro Nakajima, et al.
Current Alzheimer Research|March 12, 2019
Lead (Pb) in Alzheimer's Dementia: A Systematic Review of Human Case- Control StudiesEric E Brown, Parita Shah, Bruce G Pollock, et al.
Neuropsychologia|October 29, 2017
The neural correlates of apathy in schizophrenia: An exploratory investigationFernando Caravaggio, Gagan Fervaha, Mahesh Menon, et al.
Pageof 25